|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn958279619 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
160520s2016 nyu ob 001 0 eng |
| 010 |
|
|
|a 2020678118
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d N$T
|d EBLCP
|d OCLCF
|d YDX
|d AGLDB
|d SNK
|d DKU
|d AUW
|d INTCL
|d IGB
|d D6H
|d VTS
|d G3B
|d SCB
|d S8J
|d S9I
|d STF
|d OCLCO
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9781634855518
|q ebook
|
| 020 |
|
|
|a 1634855515
|
| 020 |
|
|
|z 9781634855099
|q (hardcover)
|
| 020 |
|
|
|z 1634855094
|q (hardcover)
|
| 029 |
1 |
|
|a AU@
|b 000067285219
|
| 035 |
|
|
|a (OCoLC)958279619
|
| 043 |
|
|
|a n-us---
|
| 050 |
0 |
0 |
|a RC931.O73
|
| 060 |
|
4 |
|a WE 250
|
| 072 |
|
7 |
|a MED
|x 092000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.716
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Osteoporosis :
|b assessment, prevalence and current treatment options /
|c Elliott Burke, editor.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2016]
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
1 |
|
|a Rheumatism and musculoskeletel disorders
|
| 504 |
|
|
|a Includes bibliography and index.
|
| 588 |
|
|
|a Description based on print version record.
|
| 505 |
0 |
|
|a OSTEOPOROSIS: ASSESSMENT, PREVALENCE AND CURRENT TREATMENT OPTIONS; OSTEOPOROSIS: ASSESSMENT, PREVALENCE AND CURRENT TREATMENT OPTIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; PREFACE; Chapter 1: HDACS AND OSTEOPOROSIS; ABSTRACT; INTRODUCTION; HDACS AND BONE FORMATION; Class I HDACs and Bone Formation; HDAC1/HDAC2; HDAC3/HDAC8; Class II HDACs and Bone Formation; HDAC4/HDAC5; HDAC6/HDAC7; Class III HDACs and Bone Formation; HDACS AND BONE RESORPTION; Class I HDACs and Bone Resorption; HDAC2/HDAC3; Class II HDACs and Bone Resorption; HDAC6/HDAC7; HDAC9
|
| 505 |
8 |
|
|a Class III HDACs and Bone ResorptionCONCLUSION; REFERENCES; BIOGRAPHICAL SKETCH; Chapter 2: MASTOCYTOSIS-INDUCED OSTEOPOROSIS: A RARE CAUSE FOR SECONDARY OSTEOPOROSIS; ABSTRACT; INTRODUCTION; MATERIALS AND METHODS; CONCLUSION; The Influence of Mast Cells on Bone; Mast Cells and Bone Turnover; Clinical Presentation of Mastocytosis-Induced Osteoporosis; Treatment Options; REFERENCES; Chapter 3: OSTEOPOROSIS AND THE STOMATOGNATHIC SYSTEM; ABSTRACT; 1. INTRODUCTION; 2. OSTEOPOROSIS; 3. THE STOMATOGNATHIC SYSTEM-ABOUT THE SYSTEM BONES; Maxilla/Jaw; Mandible; The Temporal-Mandibular Joint
|
| 505 |
8 |
|
|a 4. THE RELATIONSHIP BETWEEN OSTEOPOROSISAND THE STOMATOGNATHIC SYSTEMBisphosphonates; 5. IMPLANTOLOGY AND OSTEOPOROSIS; Osteoporosis and the Teeth Loss; CONCLUSION; REFERENCES; Chapter 4: OSTEOPOROSIS AND JAWBONES: A DENTAL PERSPECTIVE; ABSTRACT; INTRODUCTION; DENTAL RADIOGRAPHS AS A SCREENING TOOLS FOR OSTEOPOROSIS; OSTEOPOROSIS AND THE ORAL CAVITY; Periodontitis; Dental Implants; Medication-Related Osteonecrosis of the Jaws (MRONJ); CONCLUSION; REFERENCES; BIOGRAPHICAL SKETCH; Chapter 5: DENTAL TREATMENT OF A PATIENT WITH OSTEOPOROSIS; ABSTRACT; 1. INTRODUCTION; 2. BISPHOSPHONATES
|
| 505 |
8 |
|
|a 3. ADVERSE EFFECTS OF BISPHOSPHONATE INTHE ORAL CAVITY3.1. Stomatitis; 3.2. Osteonecrosis of the Jaws; 3.3. Other Adverse Effects in the Oral Cavity; 4. USE OF BISPHOSPHONATES IN TREATMENT OF OROFACIAL PATHOLOGY; 4.1. Stomatological Treatment of Patients with Osteoporosis; 4.2. General Rules for Stomatological Treatment of the So- Called Risk Patients; 4.2.1. History (Anamnesis); 4.2.2. Laboratory Tests; 4.2.3. Plan of Therapy; 4.2.4. Timing of Dental Interventions; 4.2.5. Local Anesthesia; 4.2.6. Patient-Related Issues; 4.2.7. Restorative Dentistry and Prosthodontics; 4.2.8. Endodontics
|
| 505 |
8 |
|
|a 4.2.9. Management of Periodontal Diseases4.2.10. Orthodontics; 4.2.11. Oral and Maxillofacial Surgery; 4.2.11.1. Aftercare Instructions for the Patient; 4.2.12. Implant Placement and Maintenance; CONCLUSION; REFERENCES; BIOGRAPHICAL SKETCH; Chapter 6: TREATMENT OF OSTEOPOROTIC FRACTURES: WE NEED MORE THAN FRACTURE CARE; ABSTRACT; THE PUBLIC HEALTH BURDEN OF OSTEOPOROSIS; Pharmacologic Treatment; Bisphosphonates; Denosumab; Strontium Ranelate; Bone Anabolic Agents; Secondary Fracture Prevention; Health Care Delivery Models for Secondary Prevention of Low Trauma Fracture
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Osteoporosis.
|
| 650 |
|
2 |
|a Osteoporosis
|
| 650 |
|
6 |
|a Ostéoporose.
|
| 650 |
|
7 |
|a MEDICAL
|x Osteopathy.
|2 bisacsh
|
| 650 |
|
7 |
|a Osteoporosis
|2 fast
|
| 700 |
1 |
|
|a Burke, Elliott,
|e editor.
|
| 710 |
2 |
|
|a Nova Biomedical (Publishing company),
|e publisher.
|
| 776 |
0 |
8 |
|i Print version:
|t Osteoporosis
|d New York : Nova Biomedical, [2016]
|z 9781634855099
|w (DLC) 2016942396
|
| 830 |
|
0 |
|a Rheumatism and musculoskeletel disorders.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1350585
|z Texto completo
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 13013181
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 1350585
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4691222
|
| 994 |
|
|
|a 92
|b IZTAP
|
